Viral Clearance Service Market

Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.

Viral Clearance Service Market contains market size and forecasts of Viral Clearance Service in Global, including the following market information:

Global Viral Clearance Service Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Viral Clearance Service market was valued at 419.9 million in 2021 and is projected to reach US$ 1314.4 million by 2028, at a CAGR of 17.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Basic Service Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Viral Clearance Service include Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs and Vironova Biosafety, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Viral Clearance Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Viral Clearance Service Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Viral Clearance Service Market Segment Percentages, by Type, 2021 (%)

Basic Service

Enhanced Service

Full Service

Turnkey Service

Global Viral Clearance Service Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Viral Clearance Service Market Segment Percentages, by Application, 2021 (%)

Research Institution

Pharmaceutical Industry

Others

Global Viral Clearance Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Viral Clearance Service Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Viral Clearance Service revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Viral Clearance Service revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Charles River

BioReliance (Merck)

Eurofins Scientific

Sartorius

Covance

ViruSure

Texcell

Bioscience Labs

Vironova Biosafety

M?rieux NutriSciences

WuXi AppTec

Syngene

Labor Dr. Merk